We serve (S)-4-(2-Amino-3-hydroxypropyl)phenol hydrochloride CAS:87745-27-5 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name: (S)-4-(2-Amino-3-hydroxypropyl)phenol hydrochloride
CAS.NO: 87745-27-5
Molecular Formula:C9H14ClNO2
Molecular Weight:203.66600
Synonyms:
L-Tyrosinol hydrochloride
L-Tyr-ol
Physical and Chemical Properties:
Density: /
Boiling point: 375.2ºC at 760 mmHg
Melting point: 161-165 °C(lit.)
Flash point: 180.7ºC
Refractive index: /
Specification:
Appearance:White or off-white soild
Purity:≥98%
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store at 0-5ºC.Keep the container tightly closed, put it in a tight dispenser, and store in a cool, dry place.
Application:Pharmaceutical intermediates.
Contact us for information like (S)-4-(2-Amino-3-hydroxypropyl)phenol hydrochloride chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,L-Tyr-ol physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,(S)-4-(2-Amino-3-hydroxypropyl)phenol hydrochloride Use and application,L-Tyrosinol hydrochloride technical grade,usp/ep/jp grade.
Related News: Australia has started denying entry to all travelers who have come from or transited through mainland China.2-Bromopropionyl bromide manufacturer Russia, which had temporarily stopped issuing work visas to Chinese citizens, is also halting visa-free entry for Chinese tour groups, the government said. Moscow has also stopped issuing electronic tourist visas to individual Chinese travelers.Thiophene-3,4-Dicarboxylic Acid supplier This is very visible in herbal medicines in which the API is frequently a combination of several mixtures and/or substances which when used together cause pharmacological activity on the body.5-Bromo-1-pentene vendor In recent years, China’s bulk drug companies have gradually completed the upgrade of the product structure of bulk raw materials to specialty raw materials and intermediates. The industry’s leading companies have further developed the research and development layout of high-barrier generic pharmaceutical raw materials with multiple patents that have not yet expired.Under the terms of this agreement, Inceptua will support Onconova through the pre-approval provision of intravenous rigosertib initially into a number of countries including: Australia, Denmark, Finland, France, Ireland, Italy, the Netherlands, Portugal, South Africa, Spain, and the UK.
